What Sun Ophthalmics does

The available source material for Sun Ophthalmics primarily describes Sun Pharma / Sun Pharmaceutical Industries Ltd.; ophthalmology appears as one of the therapeutic areas within Sun Pharma's Innovative Medicines business. The business serves patients and healthcare channels with pharmaceutical products across Innovative Medicines, Generic Products, and Consumer Healthcare, including specialty and retail products in dermatology, oncology, and ophthalmology.

The operating base is pharmaceutical R&D and manufacturing rather than a software platform. Sun Pharma is described as having an R&D pipeline for novel treatments, 2,000+ products, and more than 40 manufacturing facilities across five continents, with distribution through healthcare providers, hospitals, pharmacies, and global healthcare distribution networks.

Revenue is generated through pharmaceutical product sales across prescription, generic, and consumer healthcare channels; pricing details are not publicly disclosed in the supplied data. The source reports $6B+ in annual global revenue for Sun Pharma, with the U.S. market contributing approximately one-third, but it does not disclose standalone revenue or economics for a Sun Ophthalmics-only entity or ophthalmology segment.

Name

Sun Ophthalmics

Legal name

Sun Pharmaceutical Industries Ltd.

Website

https://sunophthalmics.com

Company type

Public

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Sun Ophthalmics is represented in the data as Sun Pharma’s ophthalmology-related pharmaceutical activity, serving patients and healthcare channels through innovative medicines, generics and consumer healthcare products backed by global R&D, manufacturing and distribution.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industry

Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Ophthalmic pharmaceuticals
• Eye care treatments
• Specialty medicines
• Ophthalmology products
• Prescription therapeutics

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Sun Pharma generates revenue through a diversified portfolio spanning Innovative Medicines (specialty and retail), Generic Products, and Consumer Healthcare products. The company operates globally with the U.S. market contributing approximately one-third of global revenues.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Sun Ophthalmics is the ophthalmology-focused division of Sun Pharmaceutical Industries Ltd., developing and commercializing prescription ophthalmic pharmaceutical products as part of Sun Pharma's Innovative Medicines business unit. The ophthalmology therapeutic area operates alongside dermatology and oncology within Sun Pharma's broader specialty and retail pharmaceutical portfolio. Sun Ophthalmics leverages Sun Pharma's global pharmaceutical R&D and manufacturing infrastructure to deliver eye care treatments to patients, healthcare providers, and pharmacies primarily through U.S. market operations.

Product overview

Sun Pharma operates as a global pharmaceutical company with a broadly diversified portfolio spanning three business units: Innovative Medicines (specialty and retail pharmaceuticals including dermatology, oncology, and ophthalmology), Generic Products, and Consumer Healthcare Products. The company offers 2,000+ products total, with manufacturing capabilities across more than 40 facilities on five continents. The ophthalmology focus appears under the Innovative Medicines business unit alongside dermatology and oncology therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Ophthalmology Therapeutic Area Products

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• External Innovation PartnersminorStrategic or Co-development PartnerSun Pharma actively seeks collaboration with external partners to bring breakthrough treatments to patients who need them, complementing internal R&D efforts. The company is interested in collaborating with external partners to bring breakthrough treatments to patients.

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/SunPharma_live
• YouTubeyoutube.com/channel/UCdkyfWmDFAaUA5P8GD_LVdQ
• Facebookfacebook.com/SunPharmaLive
• LinkedInlinkedin.com/company/sun-pharma/posts/?feedView=all
• Instagraminstagram.com/sunpharma_live

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sun Ophthalmics